NIR-II Fluorescence-Guided Hepatectomy Using ICG-Cisplatin Nanoprobes for HCC
NCT07295262
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Liver Cancer, Adult
Interventions
DRUG:
ICG-Cisplatin Nanoprobe (NIR-II NanoM)
PROCEDURE:
Fluorescence-guided Hepatectomy
Sponsor
West China Hospital